Top

Helix BioPharma Corp.

TSX Exchange | Feb 24, 2020, 5:26 AM EST | Real-time price

HBP $ 1.35 RT
CHANGE
-0.01 (-0.7353%)
VOLUME
900
Day Low: 1.26
Day High: 1.35
Detailed Quote
Open: 1.35
High: 1.35
Beta: 0.5832
Listed Shares Out.1: 127,891,001
Total Shares (All Classes)2: 127,891,001
Prev. Close: 1.36
Low: 1.26
VWAP: 1.3189
Market Cap1: 172,652,851
Market Cap (All Classes)2*: 172,652,851
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.08
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 3,836.73
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Helix BioPharma Corp is a Canada-based clinical-stage biopharmaceutical company focused on cancer drug development. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. The company has Tumor Defense Breakers (L-DOS47), and Tumor Attackers (CAR-T) product candidates in the pipeline. More

News Headlines for Helix BioPharma Corp.
Research
News Headlines for Helix BioPharma Corp.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.